This has been a groundbreaking year for lung cancer advancements, not only for our community, but the greater cancer community. Below are the top five milestones that have been reached for lung cancer in 2014.
- Centers for Medicare and Medicaid Services (CMS) Recommend Covering Lung Cancer Screening
- The November 10th CMS draft decision is the last major piece in a long series of validations, including the United States Preventive Services Task Force (USPSTF) final recommendation for annual lung cancer screening for those at high risk, reaffirming the lifesaving benefits of screening. The final decision, which almost always reflects the draft recommendation, will be released on February 12, 2015.
- National Cancer Institute (NCI) Issued New Scientific Framework for Small Cell Lung Cancer
- On July 1st NCI presented to Congress a scientific framework that lays out important steps needed to make advances in small cell lung cancer, one of the most lethal forms of the disease. The report was mandated by the Recalcitrant Cancer Research Act of 2013.
- Congressionally Directed Medical Research Program (CDMRP) Approved Another $10.5M for Lung Cancer Research
- On December 13th, CDMRP approved an additional $10.5M towards the Lung Cancer Research Program, bringing the total federal research funding for lung cancer to $89.5M.
- Kentucky LEADS (Lung Cancer. Education. Awareness. Detection. Survivorship) Collaborative Launches
- On November 12th the University of Kentucky, the University of Louisville and Lung Cancer Alliance partnered to lead the first of its kind project to reduce the burden of lung cancer in the state of Kentucky, which has more cases of lung cancer than any other state.
- Activation of groundbreaking clinical trial for Squamous Cell Lung Cancer, Lung Cancer Master Protocol (Lung-MAP) trial
- On June 16th Lung-MAP, a multi-drug, multi-arm, biomarker-driven clinical trial for patients with advanced squamous cell lung cancer, was announced. This innovative approach to clinical testing is poised to usher in one of the most dramatic advancements in cancer research that we have seen in years.
We know 2015 is going to be an even bigger year so stay tuned!